The weekly litigation news digest is live. Subscribe now

IP Verse

Spark Therapeutics competitive analysis

Latest patents of Spark Therapeutics opposed by its competitors

Explore Spark Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jan 8, 2026
Patent NumberPublication DateTitleTotal Oppositions

Get instant alerts of patent oppositions faced by Spark Therapeutics

EP3488007
Dec 20, 2023Scalable High Recovery Methods For Producing High Yield Recombinant Adeno-Associated Viral (Raav) Vector And Recombinant Adeno-Associated Viral (Raav) Vectors Produced Thereby1
EP3768304
Oct 12, 2022Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing Immunoglobulins6

Latest PTAB cases involving Spark Therapeutics

Discover the latest PTAB cases involving Spark Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Spark Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 8, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SPARK THERAPEUTICS - 7 - -
BAYER3156 - -
GATESIP1 - - -
HANSA BIOPHARMA2 - - -